Case series of a hybrid closed-loop system used in pregnancies in clinical practice.

Published in: Diabetes/metabolism research and reviews (2019)

CareLink® Clinical Software only reports the non-pregnant time in range. Nonetheless, this represents the first report of HCL therapy in pregnancy with a system approved by the Food and Drug Administration in non-pregnant populations.

Keyphrases

drug administration
clinical practice
preterm birth
pregnant women
pregnancy outcomes
gestational age
data analysis
mesenchymal stem cells
stem cells
risk assessment
genetic diversity
climate change
cell therapy